Skip to content
10-K

Annual Report

Edwards Lifesciences Corp EW

0001099800-26-000009

← back to feed
Filed
Feb 25, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jan 31, 2026 580.8M sh
Shares Diluted FY 2025 · Dec 31, 2025 585.8M sh
Shares Diluted FY 2025 · Dec 31, 2024 599.3M sh
Shares Diluted FY 2025 · Dec 31, 2023 609.4M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $893.4M
Stock Repurchased FY 2025 · Dec 31, 2024 $1.16B
Stock Repurchased FY 2025 · Dec 31, 2023 $879.6M
Capex FY 2025 · Dec 31, 2025 $260.2M
Capex FY 2025 · Dec 31, 2024 $252.4M
Capex FY 2025 · Dec 31, 2023 $253M
Operating Cash Flow FY 2025 · Dec 31, 2025 $1.6B
Operating Cash Flow FY 2025 · Dec 31, 2024 $542.3M
Operating Cash Flow FY 2025 · Dec 31, 2023 $895.8M
Long Term Debt FY 2025 · Dec 31, 2025 $598.3M
Long Term Debt FY 2025 · Dec 31, 2024 $597.7M
Short Term Investments FY 2025 · Dec 31, 2025 $1.29B
Short Term Investments FY 2025 · Dec 31, 2024 $930.7M
Cash And Equivalents FY 2025 · Dec 31, 2025 $2.94B
Cash And Equivalents FY 2025 · Dec 31, 2024 $3.05B
Stockholders Equity FY 2025 · Dec 31, 2025 $10.34B
Stockholders Equity FY 2025 · Dec 31, 2024 $10B
Current Liabilities FY 2025 · Dec 31, 2025 $1.81B
Current Liabilities FY 2025 · Dec 31, 2024 $1.51B
Total Liabilities FY 2025 · Dec 31, 2025 $3.36B
Total Liabilities FY 2025 · Dec 31, 2024 $2.99B
Current Assets FY 2025 · Dec 31, 2025 $6.74B
Current Assets FY 2025 · Dec 31, 2024 $6.29B
Total Assets FY 2025 · Dec 31, 2025 $13.7B
Total Assets FY 2025 · Dec 31, 2024 $13.06B
Eps Diluted FY 2025 · Dec 31, 2025 $1.83
Eps Diluted FY 2025 · Dec 31, 2024 $6.97
Eps Diluted FY 2025 · Dec 31, 2023 $2.30
Eps Basic FY 2025 · Dec 31, 2025 $1.84
Eps Basic FY 2025 · Dec 31, 2024 $6.98
Eps Basic FY 2025 · Dec 31, 2023 $2.31
Sga Expense FY 2025 · Dec 31, 2025 $2.09B
Sga Expense FY 2025 · Dec 31, 2024 $1.79B
Sga Expense restated FY 2025 · Dec 31, 2023 $1.58B
Rd Expense FY 2025 · Dec 31, 2025 $1.08B
Rd Expense FY 2025 · Dec 31, 2024 $1.05B
Rd Expense restated FY 2025 · Dec 31, 2023 $962.9M
Net Income FY 2025 · Dec 31, 2025 $1.07B
Net Income FY 2025 · Dec 31, 2024 $4.17B
Net Income FY 2025 · Dec 31, 2023 $1.4B
Operating Income FY 2025 · Dec 31, 2025 $1.26B
Operating Income FY 2025 · Dec 31, 2024 $1.38B
Operating Income restated FY 2025 · Dec 31, 2023 $1.31B
Gross Profit FY 2025 · Dec 31, 2025 $4.73B
Gross Profit FY 2025 · Dec 31, 2024 $4.32B
Gross Profit restated FY 2025 · Dec 31, 2023 $4.03B
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.33B
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.12B
Cost Of Revenue restated FY 2025 · Dec 31, 2023 $978.4M
Revenue FY 2025 · Dec 31, 2025 $6.07B
Revenue FY 2025 · Dec 31, 2024 $5.44B
Revenue restated FY 2025 · Dec 31, 2023 $5.01B